David Ingram, MD

David Ingram III, M.D.

Section Director Neonatal-Perinatal Medicine
Professor of Pediatrics
Associate Professor of Biochemistry & Molecular Biology

James W. Riley Hospital for Children
M.D.: Vanderbilt University School of Medicine, 1994
Internship and Residency: University of California and San Francisco, 1994 – 1997
Fellowship: Indiana University School of Medicine, 1998 – 2002

David Ingram, Neonatal-Perinatal Section Director. Dr. Ingram's academic interests involve two distinct areas of investigation. First, Dr. Ingram's laboratory utilizes genetically engineered mouse models to study tumor angiogenesis in childhood cancers and the development of vascular malformations in children with genetic mutations in the Ras-Erk signaling pathway. Second, his laboratory studies the biology of endothelial progenitor cells and myeloid precursors in repairing damaged blood vessels in the setting of ischemic injury and impaired vasculogenesis during development. Dr. Ingram's laboratory has also developed techniques to isolate and expand endothelial progenitor cells from human umbilical cord blood for potential use in regeneration of damaged blood vessels. Based on this work, Dr. Ingram directs the National Cancer Institute funded Angiogenesis and Endothelial Progenitor Cell Core at the Indiana University Cancer Center.